Original fundamental research starts and ENDS here.
Sectors Tags Blog
V
30 filings
Timeline Columns Start Research 8-K Categories
Legal8 Earnings7 Other4 Debt / Financing1 Executive Change1 Shareholder Meeting1
2025
Q4 3 filings
Nov
Antitrust Settlement
10 bps interchange rate reduction for 5 years
8-K
Nov
FY2025 Results Filing
Unable to extract complete financial metrics - document appears to contain only XBRL taxonomy structure without actual financial values
📌 Document filing shows extensive XBRL structure covering multiple debt instruments, geographic segments (US/Non-US), and derivative instruments, but lacks actual reported financial data
10-K
Oct
Q4 Earnings & Dividend
$0.670 quarterly dividend declared
8-K
Q3 7 filings
Sep
Director Elected
Bill Ready elected to Board, expanded from 11 to 12 members
8-K
Sep
Litigation Escrow Deposit & Share Count Reduction
$500M deposit, 1.47M share count reduction
8-K
Sep
Litigation Escrow Funding
$500M deposited into U.S. litigation escrow
8-K
Aug
Preferred Stock Release - Visa Europe Litigation
$1.4B released from Series B/C Preferred Stock
8-K
Jul
Q3 2025 Results
Information insufficient - key financial figures not provided in filing header
10-Q
Jul
Q3 Earnings & Dividend
$0.590 quarterly dividend declared
8-K
Jul
Bylaws Amendment - Director Nominations
Added cure process for deficient shareholder director nomination notices
8-K
Q2 3 filings
May
Euro Debt Offering
€3.5B notes across 4 tranches, rates 2.25%-3.875%
8-K
Apr
Q2 2025 Results
Financial data not available in provided content
10-Q
Apr
Q2 Earnings & Dividend
Q2 FY2025 results, $0.590 quarterly dividend declared
8-K
Q1 4 filings
Mar
Litigation Escrow Deposit
$375M deposited, share count reduced by ~1.08M
8-K
Jan
Q1 2025 Results
Rev $9.51B (+10.1% YoY), EPS data not clearly extractable from provided XBRL format
10-Q
Jan
Q1 Earnings + Dividend Declaration
Q1 FY2025 results announced, $0.590 quarterly dividend declared
8-K
Jan
2025 Annual Shareholder Meeting
11 directors elected, executive comp approved 91.92%, 4 shareholder proposals rejected
8-K
2024
Q4 4 filings
Dec
2025 Proxy Statement
Annual Meeting: Jan 28, 2025, FY24 Revenue: $35.9B (+10%)
DEF 14A
Nov
FY2024 Results
Unable to extract specific revenue and EPS figures from provided XBRL metadata
📌 Unable to identify specific milestone from provided XBRL metadata structure
10-K
Oct
Q4 Earnings & Dividend
$0.590 quarterly dividend declared
8-K
Oct
Litigation Escrow Deposit & Share Conversion Rate Adjustment
$1.5B deposited, share count reduced by 5.46M shares
8-K
Q3 4 filings
Sep
Litigation Escrow Funding
$1.5B deposited into litigation escrow account
8-K
Jul
Q3 2024 Results
Data insufficient for complete financials
10-Q
Jul
Q3 Earnings & Dividend
Q3 FY2024 results, $0.520 dividend declared
8-K
Jul
Preferred Stock Release
$2.7B released from Series B/C preferred stock
8-K
Q2 4 filings
May
Class B-1 Exchange Offer Settlement
Exchange offer settled May 8, 2024 with makewhole agreements and staged Class C stock transfer restrictions
8-K
May
Class B-1 Share Exchange Offer Expired
Exchange offer for Class B-1 common stock expired May 6, 2024
8-K
Apr
Q2 2024 Results
Rev $8.8B, EPS $2.51 (include YoY change if available)
10-Q
Apr
Q2 Earnings + Dividend Declaration
Q2 FY24 results released, $0.520 quarterly dividend declared
8-K
Q1 1 filings
Mar
Settlement of Merchant Antitrust Litigation
Settled longstanding interchange fee litigation with U.S. merchants
8-K
SECENDS is not affiliated with the SEC. Data from public EDGAR filings. Not financial advice.